Literature DB >> 7717298

Intracoronary diltiazem for microvascular spasm after interventional therapy.

F J Weyrens1, J Mooney, J Lesser, M R Mooney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717298     DOI: 10.1016/s0002-9149(99)80430-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.

Authors:  A Vahanian; B Lung
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Authors:  Sheraz A Nazir; Jamal N Khan; Islam Z Mahmoud; John P Greenwood; Daniel J Blackman; Vijay Kunadian; Martin Been; Keith R Abrams; Robert Wilcox; A A Jennifer Adgey; Gerry P McCann; Anthony H Gershlick
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

3.  Non-pharmaco, non-invasive management of coronary no-reflow phenomenon.

Authors:  Santosh Kumar Sinha; Mukesh Jitendra Jha; Puneet Aggarwal; Umeshwar Pandey; Awadesh Kumar Sharma; Mahmodullah Razi; Dibbendhu Khanra; Ramesh Thakur; Vinay Krishna
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-12-29

Review 4.  Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Lan Wang; Zhong Cheng; Ye Gu; Dingfeng Peng
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.